The accountancy and legal services markets have changed. But is the LLP structure a growth blocker? Read more

  • Status: Current
  • Date: 2021
  • Sector:
    • Healthcare & Pharma Services

https://www.bioscriptgroup.com/

Back to Investments

Bioscript

Bioscript is a successful medical communications and regulatory writing agency for pharmaceutical companies. Sovereign has partnered with the management team to further develop and grow the business in this highly interesting and evolving market.

Investment Background

Bioscript was founded in 2005 by entrepreneur Andrew Medley. The business flourished and soon established itself as a successful international agency in the market. Keen to further develop the business, Andrew and the management team wanted to find an investment partner to support their growth ambitions for the business. The Sovereign team had followed Bioscript for over seven years and respected the company’s people and their ambitions. A deal was agreed.

Value Creation

  • At investment, Chris Brinsmead joined the team as non-executive Chair. Chris brings more than 30 years of Pharmaceutical experience, including an executive leadership role with AstraZeneca and non-executive directorships with UDG Healthcare and Kinapse.

The Story So Far

Bioscript is an international provider of medical communications and regulatory writing services for pharmaceutical companies. The business assists clients in their communications with regulatory authorities as well as educating the medical sector on pharmaceutical products that are in mid- to late-stage clinical trials and subsequently supporting these products, post market launch, to maintain and grow sales throughout the lifecycle of the drug.

Bioscript, which focuses on the clinical end of the medical communications spectrum, in addition to regulatory writing support, has a strong reputation in the market reflected in its many longstanding customer relationships which include a number of the top 20 global pharma companies together with other pharma and biotech clients.

Sovereign has partnered with the management team to further develop and grow the business.


Back to Investments

THE FOUNDER'S PERSPECTIVE

We are very pleased to have found an investment partner that shares our ambitions for the business... We have always prided ourselves on delivering a consistently high-quality service to our clients. With Sovereign’s support, we are looking forward to creating new opportunities to develop our services and expand our geographic reach, to further enhance our client experience.

Andrew Medley / Founder & CEO / Bioscript